Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-11-13 | 2025-12-05 | 271859 |
| APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-11-20 | 2025-12-05 | 272356 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-16 | 2023-04-06 | 187238 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-29 | 190874 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-06 | 2023-05-12 | 191898 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-26 | 2023-07-21 | 193218 |
| APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-02-23 | 2024-03-29 | 220465 |
| APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2017-09-04 | 2017-12-04 | 20863 |
| APO-DEXAMETHASONE | 0.5MG | TABLET | Resolved | 2017-10-03 | 2017-11-28 | 24257 |
| APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2019-08-28 | 2020-09-09 | 92513 |
| APO-DEXAMETHASONE | 0.5MG | TABLET | Resolved | 2019-12-05 | 2020-09-21 | 100271 |
| APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2025-01-09 | 2025-01-31 | 247382 |
| APO-DEXAMETHASONE | 4MG | TABLET | Resolved | 2025-09-11 | 2025-10-03 | 267029 |
| APO-DEXLANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-06-14 | 2024-12-06 | 230576 |
| APO-DEXLANSOPRAZOLE | 60MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-06-14 | 2024-12-06 | 230579 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2019-10-09 | 2019-12-09 | 95861 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2020-08-06 | 2020-09-28 | 121894 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2022-01-07 | 2022-02-18 | 152304 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2023-01-26 | 2023-04-21 | 182361 |
| APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Resolved | 2023-08-12 | 2023-10-06 | 201704 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |